Deepak Prabhakar1, Edward L Peterson2, Yong Hu2, Rebecca C Rossom3, Frances L Lynch4, Christine Y Lu5, Beth E Waitzfelder6, Ashli A Owen-Smith7, L Keoki Williams2, Arne Beck6, Gregory E Simon8, Brian K Ahmedani2. 1. Behavioral Health Services, Henry Ford Health System, Detroit, MI. Electronic address: dprabha1@hfhs.org. 2. Center for Health Policy & Health Services Research, Henry Ford Health System, Detroit, MI. 3. HealthPartners Institute, Bloomington, MN. 4. Center for Health Research, Kaiser Permanente Northwest, Portland, OR. 5. Harvard Pilgrim Health Care, Wellesley, MA; Department of Population Medicine, Harvard Medical School, Boston, MA, USA. 6. Kaiser Permanente, Portland, OR. 7. Georgia State University, Atlanta, GA. 8. Kaiser Permanente Washington Health Research Institute, Seattle, WA.
Abstract
BACKGROUND: Patients diagnosed with skin conditions have a higher risk of comorbid psychiatric conditions and suicide-related outcomes such as suicidal ideations and behaviors. There is paucity of evidence in the US general population about the risk of suicide death in patients with dermatologic conditions. METHODS: We conducted a retrospective case-control study to investigate the risk of suicide death in patients receiving care for dermatologic conditions. This study involved 8 US health systems. A total of 2674 individuals who died by suicide (cases) were matched with 267,400 general population control individuals. RESULTS: After adjusting for age, sex, and any mental health or substance use condition, we did not find an association between death by suicide and any skin condition including conditions where clinicians are generally concerned about the risk such as acne (adjusted odds ratio [aOR] = 1.04, p = 0.814), atopic dermatitis (aOR = 0.77, p = 0.28), and psoriasis (aOR = 0.91, p = 0.64). CONCLUSION: This case-control study provides no evidence of increased risk of death by suicide in individuals with major skin disorders in the US general population.
BACKGROUND:Patients diagnosed with skin conditions have a higher risk of comorbid psychiatric conditions and suicide-related outcomes such as suicidal ideations and behaviors. There is paucity of evidence in the US general population about the risk of suicide death in patients with dermatologic conditions. METHODS: We conducted a retrospective case-control study to investigate the risk of suicide death in patients receiving care for dermatologic conditions. This study involved 8 US health systems. A total of 2674 individuals who died by suicide (cases) were matched with 267,400 general population control individuals. RESULTS: After adjusting for age, sex, and any mental health or substance use condition, we did not find an association between death by suicide and any skin condition including conditions where clinicians are generally concerned about the risk such as acne (adjusted odds ratio [aOR] = 1.04, p = 0.814), atopic dermatitis (aOR = 0.77, p = 0.28), and psoriasis (aOR = 0.91, p = 0.64). CONCLUSION: This case-control study provides no evidence of increased risk of death by suicide in individuals with major skin disorders in the US general population.
Authors: Brian K Ahmedani; Christine Stewart; Gregory E Simon; Frances Lynch; Christine Y Lu; Beth E Waitzfelder; Leif I Solberg; Ashli A Owen-Smith; Arne Beck; Laurel A Copeland; Enid M Hunkeler; Rebecca C Rossom; Keoki Williams Journal: Med Care Date: 2015-05 Impact factor: 2.983
Authors: Brian K Ahmedani; Edward L Peterson; Yong Hu; Rebecca C Rossom; Frances Lynch; Christine Y Lu; Beth E Waitzfelder; Ashli A Owen-Smith; Samuel Hubley; Deepak Prabhakar; L Keoki Williams; Nicole Zeld; Elizabeth Mutter; Arne Beck; Dennis Tolsma; Gregory E Simon Journal: Am J Prev Med Date: 2017-06-12 Impact factor: 5.043
Authors: Brian K Ahmedani; Gregory E Simon; Christine Stewart; Arne Beck; Beth E Waitzfelder; Rebecca Rossom; Frances Lynch; Ashli Owen-Smith; Enid M Hunkeler; Ursula Whiteside; Belinda H Operskalski; M Justin Coffey; Leif I Solberg Journal: J Gen Intern Med Date: 2014-02-25 Impact factor: 5.128
Authors: Mark C Hornbrook; Gene Hart; Jennifer L Ellis; Donald J Bachman; Gary Ansell; Sarah M Greene; Edward H Wagner; Roy Pardee; Mark M Schmidt; Ann Geiger; Amy L Butani; Terry Field; Hassan Fouayzi; Irina Miroshnik; Liyan Liu; Robert Diseker; Karen Wells; Rick Krajenta; Lois Lamerato; Christine Neslund Dudas Journal: J Natl Cancer Inst Monogr Date: 2005
Authors: Maurizio Pompili; Marco Innamorati; Alberto Forte; Denise Erbuto; Dorian A Lamis; Alessandra Narcisi; Claudia Rea; Diego Orsini; Andrea D'Arino; Annalisa Arcese; Samantha Bellini; Sara Trovarelli; Gianluca Serafini; Mario Amore; Antonio Costanzo; Paolo Girardi Journal: Int J Psychiatry Clin Pract Date: 2017-03-22 Impact factor: 1.812
Authors: Alan S Go; David J Magid; Barbara Wells; Sue Hee Sung; Andrea E Cassidy-Bushrow; Robert T Greenlee; Robert D Langer; Tracy A Lieu; Karen L Margolis; Frederick A Masoudi; Catherine J McNeal; Glen H Murata; Katherine M Newton; Rachel Novotny; Kristi Reynolds; Douglas W Roblin; David H Smith; Suma Vupputuri; Robert E White; Jean Olson; John S Rumsfeld; Jerry H Gurwitz Journal: Circ Cardiovasc Qual Outcomes Date: 2008-11
Authors: Deepak Prabhakar; Edward L Peterson; Yong Hu; Simran Chawa; Rebecca C Rossom; Frances L Lynch; Christine Y Lu; Beth E Waitzfelder; Ashli A Owen-Smith; L Keoki Williams; Arne Beck; Gregory E Simon; Brian K Ahmedani Journal: Crisis Date: 2020-11-05